HBPCF
Price:
$1.71
Market Cap:
$120.68M
Helix BioPharma Corp. is a Canadian enterprise focused on immuno-oncology. The company's research and development efforts include L-DOS47, a drug candidate aimed at treating non-small cell lung cancer, and V-DOS47, which is designed to interact with vascular epithelial growth factor receptor 2 (VEGFR2). Helix has established collaborative agreements to further its research. One such partnership with Moffitt Cancer Center involves studying L-DOS47's pharmacodynamics and exploring the advantages of co-administering it with immune checkpoint inhibitors. A separate collaboration with University Hospital Tuebingen focuses on evaluating L-DOS47's therapeutic impact on CEACAM6-positive cancer model...[Read more]
Industry
Biotechnology
IPO Date
2009-11-27
Stock Exchange
OTC
Ticker
HBPCF
According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -42.75. This represents a change of 0.17% compared to the average of -42.68 of the last 4 quarters.
The mean historical PE Ratio of Helix BioPharma Corp. over the last ten years is -9.08. The current -42.75 PE Ratio has changed 46.99% with respect to the historical average. Over the past ten years (40 quarters), HBPCF's PE Ratio was at its highest in in the October 2024 quarter at -1.50. The PE Ratio was at its lowest in in the April 2026 quarter at -56.34.
Average
-9.08
Median
-8.01
Minimum
-16.35
Maximum
-4.67
Discovering the peaks and valleys of Helix BioPharma Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.48%
Maximum Annual PE Ratio = -4.67
Minimum Annual Increase = -67.71%
Minimum Annual PE Ratio = -16.35
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -11.46 | 107.48% |
| 2024 | -5.52 | -14.40% |
| 2023 | -6.45 | 38.10% |
| 2022 | -4.67 | -67.71% |
| 2021 | -14.47 | 89.00% |
| 2020 | -7.65 | -3.53% |
| 2019 | -7.93 | -1.84% |
| 2018 | -8.08 | -1.45% |
| 2017 | -8.20 | -49.83% |
| 2016 | -16.35 | -9.53% |
The current PE Ratio of Helix BioPharma Corp. (HBPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.81
5-year avg
-8.51
10-year avg
-9.08
Helix BioPharma Corp.’s PE Ratio is less than MindMaze Therapeutics Holding S.A. Sponsored ADR (0), less than Calliditas Therapeutics Ab (-23.95), less than PsyBio Therapeutics Corp. (-0.00), less than MindMaze Therapeutics Holding S.A. (0), less than Arch Biopartners Inc. (-13.17), less than Amplia Therapeutics Limited (-7.46), less than ZIVO Bioscience, Inc. (-1.44), less than TransCanna Holdings Inc. (-0.04), less than Oncotelic Therapeutics, Inc. (0.09), greater than Vicapsys Life Sciences, Inc. (-123.38),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0 | $5.30M | |
| -23.95 | $19.80M | |
| -0.00 | $1.27K | |
| 0 | $4.72M | |
| -13.17 | $23.98M | |
| -7.46 | $42.09M | |
| -1.44 | $14.27M | |
| -0.04 | $11.97K | |
| 0.09 | $22.22M | |
| -123.38 | $47.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Helix BioPharma Corp.'s PE Ratio?
How is the PE Ratio calculated for Helix BioPharma Corp. (HBPCF)?
What is the highest PE Ratio for Helix BioPharma Corp. (HBPCF)?
What is the 3-year average PE Ratio for Helix BioPharma Corp. (HBPCF)?
What is the 5-year average PE Ratio for Helix BioPharma Corp. (HBPCF)?
How does the current PE Ratio for Helix BioPharma Corp. (HBPCF) compare to its historical average?